FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Nkarta's Trailing 12-Month Free Cash Flow is $-104.11 Mil, and Market Cap is $110.69 Mil. Therefore, Nkarta's FCF Yield % for today is -94.05%.
The historical rank and industry rank for Nkarta's FCF Yield % or its related term are showing as below:
NKTX'
s FCF Yield % Range Over the Past 10 Years
Min: -167.35 Med: -23.52 Max: -3.27
Current: -94.05
During the past 7 years, the highest FCF Yield % of Nkarta was -3.27%. The lowest was -167.35%. And the median was -23.52%.
NKTX's FCF Yield % is ranked worse than 80.9% of 1497
companies
in the Biotechnology industry
Industry Median: -16.25
vs NKTX: -94.05
Nkarta's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.
Nkarta FCF Yield % Historical Data
The historical data trend for Nkarta's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Nkarta's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nkarta's FCF Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nkarta's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Nkarta's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nkarta FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Nkarta FCF Yield % Related Terms
Thank you for viewing the detailed overview of Nkarta's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NKTX has been successfully added to your 